SHOULDER INNOVATIONS, INC. 8-K Filing

From the Filing

0001699350-25-000020.txt : 20251203 0001699350-25-000020.hdr.sgml : 20251203 20251203071053 ACCESSION NUMBER: 0001699350-25-000020 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20251203 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251203 DATE AS OF CHANGE: 20251203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SHOULDER INNOVATIONS, INC. CENTRAL INDEX KEY: 0001699350 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 270538764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-42771 FILM NUMBER: 251544983 BUSINESS ADDRESS: STREET 1: 1535 STEELE AVENUE SW, SUITE B CITY: GRAND RAPIDS STATE: MI ZIP: 49507 BUSINESS PHONE: 616-566-0286 MAIL ADDRESS: STREET 1: 1535 STEELE AVENUE SW, SUITE B CITY: GRAND RAPIDS STATE: MI ZIP: 49507 8-K 1 si-20251203.htm 8-K si-20251203 0001699350 false 0001699350 2025-12-03 2025-12-03 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________________ FORM 8-K ___________________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 3, 2025 ___________________________________________ SHOULDER INNOVATIONS, INC. (Exact name of registrant as specified in its charter) Delaware 001-42771 27-0538764 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 1535 Steele Avenue SW, Suite B Grand Rapids , Michigan 49507 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (616) 294-1026 Not Applicable (Former name or former address, if changed since last report) ___________________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol Name of each exchange on which registered Common Stock,$0.001 par value per share SI New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company x If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 7.01.    Regulation FD Disclosure. On December 3, 2025, Shoulder Innovations, Inc. (the “Company”) issued a press release announcing its strategic partnership with Interventional Systems to introduce a robotic platform for shoulder arthroplasty. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information contained in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes